Company Directory / Biotechnology
Public · NASDAQ:SAGEFor profitBiotechnologyCambridge, MA, United States
SAGE Therapeutics
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
- Founded
- 2010 16 years ago
- Staff
- 501-1000 478 on LinkedIn
- Followers
- 111k on LinkedIn
- Funding
- $2.7B as listed, USD
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life… Read all
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more than just a destination. We’re concerned with the journey, and we care deeply about everyone contributing to and benefiting from our own company journey. This means helping people discover the right path for them and carefully guiding colleagues along the way. Read our Community Guidelines: http://bit.ly/2tFyAoj
Set against six million companies
Size
501-1000 people: larger than 95% of companies with a size listed. 478 people list it on LinkedIn.
Age
16 years old.
Reach
Website ranked #1,407,444 in the world for traffic, about 18k visits a month. 111,268 followers on LinkedIn.
What it does
BiotechnologyHealth CareMedicalTherapeuticsCNS disordersNeuroscienceBrain HealthMental Healthbrain disorders
Funding, as listed
$2.7B raised in total
- Rounds10
- LatestPost ipo equity, Nov 2020
- Latest amountUSD 650,000,000
- Investors6, 2 leading
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Every detail we hold
Everything the source datasets list about SAGE Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- SAGE Therapeutics
- Type
- For profit
- Status
- Public · NASDAQ:SAGE
- Founded
- 2010
- Founders
- Douglas Covey, Steven Paul
- Industry
- Biotechnology
- Categories
- Biotechnology, Health Care, Medical, Therapeutics
- Specialities
- CNS disorders, Neuroscience, Brain Health, Mental Health, brain disorders
Where
- City
- Cambridge
- Region
- MA
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 501-1000
- People on LinkedIn
- 478
- LinkedIn followers
- 111,268
- Web traffic rank
- #1,407,444
- Monthly web visits
- 18,090
- Apps
- 4
Funding, as listed
- Total
- $2,701,000,000 USD
- Rounds
- 10
- Latest round
- Post ipo equity
- Latest round date
- Nov 2020
- Latest amount
- 650,000,000 USD
- Investors
- 6
- Lead investors
- 2
- Stock listing
- NASDAQ:SAGE
- Listing status
- public
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
SAGE Therapeutics may be growing as evidenced by recent financial and business developments. Analysts have boosted their estimates following the company's earnings report, indicating a positive outlook on the company's financial performance. Additionally, the company has been 'highly encouraged' by the launch of its new product, Zurzuvae, in partnership with Biogen, although specific sales projections have not been offered. Furthermore, SAGE Therapeutics has reported strong financial results for the first quarter of 2024, with revenues exceeding expectations, which suggests an upward trajectory in its business operations.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Biotechnology in United States.
InsmedBridgewater Township · 501-1000 people · 51k followers
InvitaeSan Francisco · 1001-5000 people · 146k followers
Amicus TherapeuticsPrinceton · 501-1000 people · 48k followers
GrailMenlo Park · 1001-5000 people
PacBioMenlo Park · 501-1000 people · 85k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.